ArticleBritish journal of cancer2025

Long-term clinical outcome of patients with metastatic melanoma and initial stable disease during anti-PD-1 checkpoint inhibitor immunotherapy with pembrolizumab.

Inge Mansfield Noringriis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.